SEARCH

SEARCH BY CITATION

References

  • 1
    Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145 60.
  • 2
    Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205 8.
  • 3
    Small PK, Loudon MA, Waldron B, Smith D, Campbell FC. Importance of reflux symptoms in functional dyspepsia. Gut 1995; 36: 189 92.
  • 4
    Talley NJ. Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther 1997; 11(Suppl. 2): 1 8.
  • 5
    Armstrong D. Helicobacter pylori infection and dyspepsia . Scand J Gastroenterol 1996; 31(Suppl. 215): 38 47.
  • 6
    Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J 1991; 302: 749 52.
  • 7
    Richter JE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 182(Suppl): 11 16.
  • 8
    Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995; 30: 519 23.
  • 9
    Nyren O, Adami HO, Gustavsson S, Lindgren PG, Loof L, Nyberg A. The ‘epigastric distress syndrome’. A possible disease entity identified by history and endoscopy in patients with nonulcer dyspepsia. J Clin Gastroenterol 1987; 9: 303 9.
  • 10
    Heikkinen MT, Pikkarainen PH, Takala JK, et al.Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy. Scand J Prim Health Care 1997; 15: 82 6.
  • 11
    Klauser AG, Voderholzer WA, Knesewitsch PA, et al. What is behind dyspepsia? Dig Dis Sci 1993; 38: 147 54.
  • 12
    Talley NJ & Phillips SF. Non-ulcer dyspepsia: Potential causes and pathophysiology. Ann Intern Med 1988; 108: 865 79.
  • 13
    Talley NJ, Silverstein M, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA Technical Review – evaluation of dyspepsia. Gastroenterology 1998; 114: 582 95.
  • 14
    Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7: 829 33.
  • 15
    Talley NJ, McNeil D, Hayden A, Colreavy C, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology 1987; 92: 1060 6.
  • 16
    Haug TT, Wilhelmsen I, Ursin H, Berstad A. What are the real problems for patients with functional dyspepsia? Scand J Gastroenterol 1995; 30: 97 100.
  • 17
    Lydeard S & Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495 8.
  • 18
    Kurata JH, Nogawa AN, Chen YK, Parker CE. Dyspepsia in primary care: perceived causes, reasons for improvement and satisfaction with care. J Fam Pract 1997; 44: 281 8.
  • 19
    Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: How important are psychological factors? Dig Dis Sci 1998; 43: 1016 22.
  • 20
    American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985; 102: 266 9.
  • 21
    Howden CW. For what conditions is there evidence-based justification for treatment of Helicobacter pylori infection? Gastroenterology 1997; 113(Suppl. 6): S107 12.
  • 22
    Malfertheiner P, Megraud F, O’Morain C, et al.Current European concepts in the management of Helicobacter pylori infection – the Maastricht Consensus report. Eur J Gastroenterol Hepatol 1997; 9: 1 2.
  • 23
    Lam SK & Talley NJ. Report of the 1997 Asia Pacific Consensus Guidelines on the Management of H. pylori. J Gastroenterol Hepatol 1998; 13: 1 12.
  • 24
    Hunt RH & Thompson ABR. Canadian Helicobacter pylori consensus conference. Can J Gastroenterol 1998; 12: 31 41.
  • 25
    Colin-Jones DG, Bloom B, Bodemar G, et al.Management of dyspepsia. Report of a Working Party. Lancet 1988; 1: 576 9.
  • 26
    Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III Dyspepsia and dyspepsia subgroups: a population based study. Gastroenterology 1992; 102: 1259 68.
  • 27
    Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378 86.
  • 28
    Mann J, Holdstock G, Harman M, et al.Scoring system to improve cost effectiveness of open access endoscopy. Br Med J 1983; 287: 937 40.
  • 29
    Crean GP, Holden RJ, Knill-Jones RP, et al.A database on dyspepsia. Gut 1994; 35: 191 202.
  • 30
    Lindberg G, Seensalu R, Nilsson LH, et al.Transferability of a computer system for medical history taking and decision support in dyspepsia. A comparison of indicants for peptic ulcer. Scand J Gastroenterol 1987; 22(Suppl. 128): 190 6.
  • 31
    Bytzer P & Schaffalitzky de Muckadell OB. Prediction of major pathologic conditions in dyspeptic patients referred for endoscopy. A prospective evaluation of a scoring system. Scand J Gastroenterol 1992; 27: 987 92.
  • 32
    Bytzer P, Hansen JM, Havelund T, et al.Predicting endoscopic diagnosis in the dyspeptic patient. The value of clinical judgement. Eur J Gastroenterol Hepatol 1996; 8: 359 63.
  • 33
    Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB, Malchow-Moller A. Predicting endoscopic diagnosis in dyspeptic patients. The value of predictive score models. Scand J Gastroenterol 1997; 32: 118 25.
  • 34
    Heading RC, Wager E, Tooley PJ. Reliability of symptom assessment in dyspepsia. Eur J Gastroenterol Hepatol 1997; 9: 779 81.
  • 35
    Williams B, Luckas M, Ellingham JH, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet 1988; 2: 1349 51.
  • 36
    Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997; 41: 513 7.
  • 37
    Johannessen T, Petersen H, Kleveland PM, et al.The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25: 689 97.
  • 38
    Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996; 38: 822 5.
  • 39
    Adang RP, Vismans JF, Talmon JL, Hasman A, Ambergen AW, Stockbrugger RW. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastroint Endosc 1995; 42: 390 7.
  • 40
    Horrocks JC & De Dombal FT. Clinical presentation of patients with ‘dyspepsia’. Detailed symptomatic study of 360 patients. Gut 1978; 19: 19 26.
  • 41
    Gillen D & McColl KEL. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 1999; 94: 75 9.
    Direct Link:
  • 42
    Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811 6.
  • 43
    Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998; 47: 449 54.
  • 44
    Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988; 232: 75 6.
  • 45
    Sorbi D, Gostout CJ, Pasha T, Lindor KD. Small caliber esophago gastroduodenoscopy without sedation: a prospective study of healthy volunteers. Gastroint Endosc 1998; 47: AB40AB40.
  • 46
    Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997; 112: 1376 80.
  • 47
    Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72 83.
  • 48
    McColl KEL, El-Nujumi A, Murray L, et al.The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997; 40: 302 6.
  • 49
    Patel P, Khulusi S, Mendall MA, et al.Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315 8.
  • 50
    Vaira D, Stanghellini V, Menegatti M, et al.Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? Endoscopy 1997; 29: 595 601.
  • 51
    Fraser AG, Ali MR, McCullogh S, et al.Diagnostic tests for Helicobacter pylori –can they select patients for endoscopy? NZ Med J 1996; 109: 95 8.
  • 52
    Xia HH-X, Kalantar J, Ma Wyatt J, et al.Failure of Helicobacter pylori serology to identify most peptic ulcer disease in patients with dyspepsia. Gastroenterology 1998; 114: A336A336(Abstract).
  • 53
    Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol 1996; 91: 1138 44.
  • 54
    Agreus L & Talley N. Challenges in managing dyspepsia in general practice. Br Med J 1997; 315: 1284 8.
  • 55
    Axon ATR, Bell GD, Jones RH, et al.Guidelines on appropriate indication for upper gastrointestinal endoscopy. Br Med J 1995; 310: 853 6.
  • 56
    Forbes GM, Glaser ME, Cullen DJ, et al.Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258 60.
  • 57
    Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442 7.
  • 58
    Xia HH-X & Talley NJ. Helicobacter pylori infection, atrophic gastritis and reflux esophagitis: an unexplored triangle . Am J Gastroenterol 1998; 93: 394 400.
    Direct Link:
  • 59
    Talley NJ. Functional dyspepsia – Should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107 15.
  • 60
    Nyren O, Adami HO, Bates S, et al.Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339 43.
  • 61
    Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology 1986; 91: 149 56.
  • 62
    Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169 77.
  • 63
    Finney JS, Kinnersley N, Hughes M, Obrantear CG, Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroent 1998; 26: 312 20.
  • 64
    Holtmann G & Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs 1993; 45: 918 30.
  • 65
    Talley NJ, Meineche-Schmidt V, Pare P, et al.Efficacy of omeprazole in non-ulcer dyspepsia: a double-blind randomized placebo-controlled trial. Aliment Pharmacol Ther 1998; 12: 1055 65.
  • 66
    Jones RH & Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997; 11: 541 6.
  • 67
    Tucci A, Corinaldesi R, Stanghellini V, et al.Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992; 103: 768 74.
  • 68
    El-Omar E, Penman I, Ardill JE, McColl KE. A substantial porportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 26: 534 8.
  • 69
    Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457 64.
  • 70
    Farup PG, Hovde O, Breder O. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? Scand J Gastroenterol 1995; 30: 829 32.
  • 71
    Talley NJ. H. pylori and dyspepsia. Yale J Biol Med 1999 in press.
  • 72
    George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with non-ulcer dyspepsia. Gastroenterology 1991; 101: 3 6.
  • 73
    Joffe SN & Primrose JN. Pain provocation test in peptic duodenitis. Gastrointest Endosc 1983; 29: 282 4.
  • 74
    Veldhuyzen van Zanten S & Talley NJ. Cisapride for treatment of non-ulcer dyspepsia (NUD): a meta-analysis of randomized controlled trials. Gastroenterology 1998; 114: A323A323(Abstract).
  • 75
    Kellow JE, Cowan H, Shuter B, et al.Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 153 60.
  • 76
    Tack J, Broekaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 761 6.
  • 77
    Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia . Gastroenterology 1994; 106: 1174 83.
  • 78
    Laheij RJF, Jansen JBMJ, Van De Lisdonk EH, Severens JL, Verbeek ALM. Review article: Symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1996; 10: 843 50.
  • 79
    Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomized double-blind placebo-controlled trial with 12 months’ follow-up. BMJ 1999; 318: 833 7.
  • 80
    Gilvarry J, Buckley MJM, Beattie S, Hamilton H, O’Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32: 535 40.
  • 81
    McColl KEL, Murray LS, El-Omar E, et al.Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. NEJM 1998; 339: 1869 74.
  • 82
    Blum A, Talley NJ, O’Morain C, et al.Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. NEJM 1998; 339: 1875 81.
  • 83
    Bolling Sternevald E, Talley NJ, Blum AL et al. Does cure of Helicobacter pylori (Hp) improve symptoms in patients with functional dyspepsia? Am J Gastroenterol 1998; 93: 16501650 (abstract).
  • 84
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al.Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997 2000.
  • 85
    Bates S, Sjoden P, Nyren O. Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988; 17: 155 65.
  • 86
    Haug TT, Wilhelmsen I, Svebak S, Berstad A, Ursin H. Psychotherapy in functional dyspepsia. J Psychosom Res 1994; 38: 735 44.
  • 87
    Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 160 5.
    Direct Link:
  • 88
    Read NW, Abitbol JL, Bardhan KD, Whorwell PJ, Fraitag B. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997; 41: 664 8.
  • 89
    Fraitag B, Homerin M, Hecketsweiler P. Double-blind dose–response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994; 39: 1072 7.
  • 90
    Talley NJ. Visceral analgesics and functional dyspepsia – have we found the Holy Grail? Gut 1997; 41: 717 8.
  • 91
    Maxton DG, Morris J, Whorwell PJ. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharmacol Ther 1996; 10: 595 9.
  • 92
    Tack J, Piessevaux H, Coulie B, Caenepeal B, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346 52.
  • 93
    Stanghellini V, Tosetti C, Paternico A, et al.Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036 42.
  • 94
    Talley NJ, Lam SK, Goh KL, Fock KM. Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region. J Gastroenterol Hepatol 1998; 13: 335 53.
  • 95
    Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative treatment strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260 8.
  • 96
    Ofman JJ, Etchason J, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences . Ann Intern Med 1997; 126: 280 91.
  • 97
    Briggs AH, Sculpher MJ, Logan RPH, Aldous J, Ramsay ME, Baron JH. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age . Br Med J 1996; 312: 1321 5.
  • 98
    Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol 1996; 91: 1773 7.
  • 99
    Heaney A, Collins JSA, Watson RGP, McFarland RJ, Bamford KB, Tham TCK. A prospective randomised trial for a test and treat policy versus gastroscopy in young H. pylori positive dyspeptic patients. Gut 1998; 42(Suppl. 1): A17A17(Abstract).
  • 100
    Jones RH, Tait CL, Sladen G, Weston-Baker J. A Helicobacter test and treat strategy: costs and outcomes in a randomised controlled trial in primary care . Gut 1998 42(Suppl. 1): A81A81(Abstract).
  • 101
    Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. H. pylori test and treat or prompt endoscopy for dyspeptic patients in primary care. A randomized controlled trial of two management strategies: one year follow-up. Gastroenterology 1998; 114: A196A196(Abstract).
  • 102
    Duggan A, Elliott C, Logan RPH, Hawkey C, Logan RFA. Does near patient H. pylori testing in primary care reduce referral for endoscopy? Results from a randomised trial. Gut 1998; 42(Suppl. 1): A82A82(Abstract).
  • 103
    Axon A & Forman D. Helicobacter gastroduodentitis – a serious infectious disease: antibiotic treatment may prevent deaths in decades ahead. Br Med J 1997; 314: 1430 1.